Diastolic heart failure in elderly: The prognostic factors and interventions regarding heart failure with preserved ejection fraction

International Journal of Cardiology

Volumn 138, Issue 3, 2010, Pages 311-313

  Acikel, Sadik ^a   Akdemir, Ramazan ^a   Kilic, Harun ^a   Yesilay, Asuman Bicer ^a   Dogan, Mehmet ^a   Cagirci, Goksel ^a  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Diastolic heart failure; Elderly; Prognosis

Indexed keywords

CANDESARTAN; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NEBIVOLOL; PERINDOPRIL; PLACEBO;

AGING; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONGESTIVE HEART FAILURE; DIASTOLIC HEART FAILURE; DISEASE PREDISPOSITION; ELDERLY CARE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL READMISSION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MORBIDITY; MORTALITY; PALLIATIVE THERAPY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SYSTOLIC DYSFUNCTION;

AGED; COMORBIDITY; HEART FAILURE, DIASTOLIC; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STROKE VOLUME;

EID: 74649083930     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.06.068     Document Type: Article

References (31)

1. Pérez de Isla L., Cañadas V., Contreras L., et al. Diastolic heart failure in 182 the elderly: in-hospital and long-term outcome after the first episode. Int J Cardiol 134 (2009) 265-270
2. Mcdonald K. Diastolic heart failure in the elderly: underlying mechanisms and clinical relevance. Int J Cardiol 125 (2008) 197-202
3. Kitzman D.W. Diastolic heart failure in the elderly. Heart Fail Rev 7 (2002) 17-27
4. East M.A., Peterson E.D., Shaw L.K., Gattis W.A., and O'Connor C.M. Racial differences in the outcomes of patients with diastolic heart failure. Am Heart J 148 (2004) 151-156
5. Shammas R.L., Khan N.U., Nekkanti R., and Movahed A. Diastolic heart failure and left ventricular diastolic dysfunction: what we know, and what we don't know!. Int J Cardiol (2007) 115:284-292
6. Cohn J.N., and Jonhson G. Heart failure with normal ejection fraction. The V-Heft Study. Veterans Administration Cooperative Study Group. Circulation 81 (1990) III48-III53
7. Ghali J.K., Kadakia S., Bhatt A., Cooper R., and Liao Y. Survival of heart failure patients with preserved versus impaired systolic function: the prognostic implication of blood pressure. Am Heart J 123 (1992) 993-997
8. Vasan R.S., Larson M., Benjamin E., Evans J., Reis C., and Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 33 (1999) 1948-1955
9. Smith G.L., Masoudi F.A., Vaccarino V., Radford M.J., and Krumholz H.M. Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol 41 (2003) 1510-1518
10. Yusuf S., Pfeffer M.A., Swedberg K., et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved trial. Lancet 362 (2003) 777-781
11. Bhatia R.S., Tu J.V., Lee D.S., et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355 (2006) 260-269
12. Fonarow G.C., Stough W.G., Abraham W.T., et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol 50 (2007) 768-777
13. Fung J.W., Sanderson J.E., Yip G.W., Zhang Q., and Yu C.M. Impact of atrial fibrillation in heart failure with normal ejection fraction: a clinical and echocardiographic study. J Card Fail 13 (2007) 649-655
14. Parkash R., Maisel W.H., Toca F.M., and Stevenson W.G. Atrial fibrillation in heart failure: high mortality risk even if ventricular function is preserved. Am Heart J 150 (2005) 701-706
15. Yancy C.W., Lopatin M., Stevenson L.W., De Marco T., and Fonarow G.C. ADHERE Scientific Advisory Committee and Investigators. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 47 (2006) 76-84
16. Jones R.C., Francis G.S., and Lauer M.S. Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial. J Am Coll Cardiol 44 (2004) 1025-1029
17. Hunt S.A. American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46 (2005) e1-82
18. Swedberg K., Cleland J., Dargie H., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
19. Heart Failure Society of America. Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail 12 (2006) 10-38
20. Dauterman K.W., Go A.S., Rowell R., Gebretsadik T., Gettner S., and Massie B.M. Congestive heart failure with preserved systolic function in a statewide sample of community hospitals. J Card Fail 7 (2001) 221-228
21. Carson P., Johnson G., Fletcher R., and Cohn J. Mild systolic dysfunction in heart failure (left ventricular ejection faction > 35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HEFT). J Am Coll Cardiol 27 (1996) 642-649
22. Eriksson S.V., Kjekshus J., Offstad J., and Swedberg K. Patient characteristics in cases of chronic severe heart failure with different degrees of left ventricular systolic dysfunction. Cardiology 85 (1994) 137-144
23. Cleland J.G., Tendera M., Adamus J., Freemantle N., Polonski L., and Taylor J. PEP-CHF Investigators. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 27 (2006) 2338-2345
24. Coats A.J. Beta-adrenoceptor antagonists in elderly patients with chronic heart failure: therapeutic potential of third-generation agents. Drugs Aging 23 (2006) 93-99
25. Flather M.D., Shibata M.C., Coats A.J., et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 26 (2005) 215-225
26. Ahmed A., Rich M.W., Love T.E., et al. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J 27 (2006) 178-186
27. Fukuta H., Sane D.C., Brucks S., and Little W.C. Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report. Circulation 112 (2005) 357-363
28. Shah R., Wang Y., and Foody J.M. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients > or = 65 years of age with heart failure and preserved left ventricular systolic function. Am J Cardiol 101 (2008) 217-222
29. Teo K., Yusuf S., Sleight P., et al. Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials. Am Heart J 148 (2004) 52-61
30. McMurray J.J., Carson P.E., Komajda M., et al. Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial. Eur J Heart Fail 10 (2008) 149-156
31. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150